| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |